Topic: Health Care

FOIA to ACF Seeking Email Communications with “Abortion Reversal” Advocates

September 6, 2019
FOIA request to the Administration for Children and Families (ACF) seeking email communications with Dr. George Delgado and other advocates of “abortion reversal.” American Oversight seeks to shed light on whether and to what extent abortion reversal has gained support among federal officials, and whether any action has been taken on this issue.

FOIA to ACF Seeking Email Communications Regarding “Abortion Reversal”

September 6, 2019
FOIA request to the Administration for Children and Families (ACF) seeking email communications regarding “abortion reversal.” American Oversight seeks to shed light on whether and to what extent abortion reversal has gained support among federal officials, and whether any action has been taken on this issue.

FOIA to CMS Seeking Email Communications with “Abortion Reversal” Advocates

September 6, 2019
FOIA request to the Centers for Medicare & Medicaid Services (CMS) seeking email communications with Dr. George Delgado and other advocates of “abortion reversal.” American Oversight seeks to shed light on whether and to what extent abortion reversal has gained support among federal officials, and whether any action has been taken on this issue.

FOIA to CMS Seeking Email Communications Regarding “Abortion Reversal”

September 6, 2019
FOIA request to the Centers for Medicare & Medicaid Services (CMS) seeking email communications regarding “abortion reversal.” American Oversight seeks to shed light on whether and to what extent abortion reversal has gained support among federal officials, and whether any action has been taken on this issue.

FOIA to FDA Seeking Email Communications Between FDA Officials and Mar-a-Lago Trio

September 4, 2019
FOIA request to the U.S. Food & Drug Administration seeking email communications between FDA officials and the Mar-a-Lago Trio regarding the anti-depressant nasal spray Spravato (esketamine).

FOIA to FDA Seeking Email Communications with the White House Regarding the Anti-Depressant Nasal Spray Spravato

September 4, 2019
FOIA request to the U.S. Food & Drug Administration seeking email communications between FDA officials and the White House regarding the anti-depressant nasal spray Spravato (esketamine).

FOIA to VA Seeking Email Communications Between VA Officials and Mar-a-Lago Trio

September 4, 2019
FOIA request to the Department of Veterans Affairs seeking email communications between VA officials and the Mar-a-Lago Trio. American Oversight seeks to shed light on whether the White House and close allies of the president influenced federal action regarding the nasal spray Spravato.

FOIA to VA Seeking Email Communications with the White House Regarding the Anti-Depressant Nasal Spray Spravato

September 4, 2019
FOIA request to the U.S. Department of Veterans Affairs seeking email communications between VA officials and the White House regarding the anti-depressant nasal spray Spravato (esketamine).

FOIA to VA Seeking Email Communications Between VA Officials and Spravato Manufacturers

September 4, 2019
FOIA request to the Department of Veterans Affairs seeking email communications between VA officials, Janssen, and Johnson & Johnson executives regarding the anti-depressant nasal spray Spravato (esketamine).

FOIA to VA Seeking Emails Sent by VA Officials Regarding an Anti-Depressant Nasal Spray

September 4, 2019
FOIA request to the U.S. Department of Veterans Affairs seeking email communications from VA officials regarding the anti-depressant nasal spray Spravato (esketamine), on key dates.